CDy11
CDy11 is a fluorescent probe and amyloid-binding dye (λex=590 nm; λem=612 nm), with a Ka of 29 μM for Pseudomonas aeruginosa Fap. CDy11 specifically recognizes amyloid fibrils in bacterial biofilms and exhibits significantly enhanced fluorescence upon binding to the target. CDy11 shows no staining effect on amyloid-deficient mutant strains, planktonic cells or protein monomers. CDy11 supports in vivo imaging of Pseudomonas aeruginosa biofilms in mouse implant and corneal infection models. CDy11 is widely used in studies of Staphylococcus aureus biofilm infections, dental caries, and Pseudomonas aeruginosa-associated implant and corneal infections.
For research use only. We do not sell to patients.
- CAS No.: 2028316-07-4
- Formula: C27H23BF3N3O2
- Molecular Weight:489.30
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
CDy11 (100 μM; 45 minutes) specifically detects amyloid fibril matrix components of Staphylococcus aureus GFP-SH1000 biofilm-coated silica microbeads, producing a strong red fluorescent signal that co-localizes with bacterial green fluorescence[1].
CDy11 detects Pseudomonas aeruginosa biofilms with a limit of 8×108 CFU/mL[2].
CDy11 (1 μM; 1 h) co-localizes with Fap-specific antibody staining in Pseudomonas aeruginosa PAO1 biofilms, confirming specific binding to Fap amyloid[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Black mice with P. aeruginosa corneal infection[2]
-
Dosage:5 μM
-
Administration:Topical drop; single dose; 10-minute incubation followed by PBS wash
-
Result:Detected clear fluorescence signals in P.
aeruginosa-infected corneas, while no obvious signal was detected in control scratched eyes treated only with PBS.
Peaked in fluorescence intensity 10 minutes post-incubation, with most signal eliminated within 1 hour.
Showed signals colocalized with GFP signals from P.
aeruginosa and Cy5 signals from Fap (functional amyloid in Pseudomonas) antibody in immunohistochemical analysis of extracted eye sections.
Chemical Information
-
CAS No. 2028316-07-4
-
Molecular Weight 489.30
-
Formula C27H23BF3N3O2
-
SMILES
CC(C=C1/C=C/C2=C(F)C=C(OC)C=C2)=C(N1[B-]3(F)F)C(C4=CC=C(NC(C)=O)C=C4)=C5[N+]3=CC=C5
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Bioluminescent/Fluorescent Imaging Xenograft
Bioluminescent and fluorescent imaging xenograft models use tumor cells engineered to express optical reporters so tumor engraftment, growth, dissemination, and treatment response can be monitored longitudinally in living animals and validated ex vivo. Bioluminescence imaging usually measures luciferase activity after substrate administration and is commonly used as a surrogate for viable reporter-expressing tumor burden, while fluorescence imaging measures reporter or probe emission and can support tumor localization, ex vivo confirmation, or complementary multimodal analysis.
-
Amyloid: Congo Red Amyloid Staining
Congo red amyloid staining is a histochemical method used to detect extracellular amyloid deposits in tissue sections based on the affinity of Congo red dye for β-pleated sheet-rich protein aggregates. When bound to amyloid, Congo red produces characteristic apple-green birefringence under polarized light microscopy, which is widely regarded as a diagnostic feature of amyloid deposition in histopathology. The diagnostic principle relies on the combination of dye binding (congophilia) and optical anisotropy under polarized illumination, which distinguishes amyloid from most non-amyloid eosinophilic extracellular deposits in routine histological evaluation. Amyloid identification by Congo red staining remains a cornerstone in diagnostic pathology despite the availability of adjunct methods such as immunohistochemistry and mass spectrometry, particularly because of its ability to localize deposits directly within tissue architecture. The specificity of Congo red-positive deposits is incre
Purity & Documentation
References
[1]. Sauvat L, et al. Biofilm-coated microbeads and the mouse ear skin: An innovative model for analysing anti-biofilm immune response in vivo. PLoS One. 2020;15(12):e0243500. Published 2020 Dec 4. [Content Brief]
[2]. Kim JY, et al. Detection of Pathogenic Biofilms with Bacterial Amyloid Targeting Fluorescent Probe, CDy11. J Am Chem Soc. 2016;138(1):402-407. [Content Brief]
[3]. Barran-Berdon AL, et al. Enhanced purification coupled with biophysical analyses shows cross-β structure as a core building block for Streptococcus mutans functional amyloids. Sci Rep. 2020;10(1):5138. Published 2020 Mar 20. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)